What’s next for oncology research?
R&D
Eliminating cancer as a cause of death is a highly ambitious goal, but oncology researchers are showing no signs of giving up the fight in 2023. To find out more, pharmaphorum editor-in-chief, Jonah Comstock sat down with SVP and head of oncology at AstraZeneca, Mohit Manrao, to discuss key oncology trends for 2023, and AstraZeneca’s ongoing work to eradicate cancer.
Check out the full interview to learn more:
• Read the full article in pharmaphorum's Deep Dive digital magazine
